1. 1) H. von der Maase, Gemcitabine in locally advanced And /or metastatic bladder cancer, Critical Reviews in Oncology/ Hematology, 34, 175-184 (2000).
2. 2) H.M. Khaled, M.R. Hamza, O. Mansour, R. Gaafar, M.S. Zaghloul, A phase II study of gemcitabine plus cisplatin chemotherapy in advanced bilharzial bladder carcinoma, European Journal of Cancer, 36, s34-s37 (2000).
3. 3) H. von der Maase, S.W. Hansen, J.T. Roberts, L. Dogliotti, T. Oliver, M.J. Moore, I. Bodrogi, P. Albers, A. Knuth, C.M. Lippert, P. Kerbrat, P. Sanchez Rovira, P. Wersall, S.P. Cleall, D.F. Roychowdhury, I. Tomlin, C.M. Visseren-Grul, P.F. Conte, Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study, J. Clin. Oncol., 17, 3068-3077 (2000).
4. Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer
5. 5) C.N. Sternberg, Gemcitabine in Bladder Cancer, Semin. Oncol., 27, 31-39 (2000).